Maaike M Hofman

3PUBLICATIONS
32CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|May 06, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC after Immune Checkpoint Blockade.

|Dec 26, 2025
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.

Ruben Malmberg, Maaike M Hofman, Fatima Ashad

Pageof 1

Frequent Collaborators

3 joint publications

Ron H J Mathijssen

2 joint publications

Astrid A M van der Veldt

2 joint publications

Arjen Joosse

2 joint publications

Joachim G J V Aerts

2 joint publications

Christianne Groeneveldt

2 joint publications

Daphne W Dumoulin

1 joint publications

Ruben Malmberg

1 joint publications

Stefani Oosterveld

1 joint publications

Esther Oomen-de Hoop

1 joint publications

Maria E Joosse

Frequent Collaborators

3 joint publications

Ron H J Mathijssen

2 joint publications

Astrid A M van der Veldt

2 joint publications

Arjen Joosse

2 joint publications

Joachim G J V Aerts

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us